HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


AMAG: Amag Pharmaceuticals Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
AMAG PHARMACEUTICALS INC (NASD)
AMAG 39.75 -0.06 (-0.15%) Vol.  483,665 16.00 CST

Nov 12, 2009 AMAG Pharmaceuticals, Inc. to Participate in the Lazard Capital Markets 6th Annual Healthcare Conference
Nov 12, 2009 AMAG Pharmaceuticals Up 7.2% Since SmarTrend's Buy Recommendation
Oct 31, 2009 AMAG Pharmaceuticals Down 8.6% Since SmarTrend's Sell Recommendation
Oct 30, 2009 BiomedReports: News and FDA Updates for Curis (NASDAQ:CRIS), AMAG (NASDAQ:AMAG), King (NYSE:KG), Sucampo (NASDAQ:SCMP)
Oct 29, 2009 AMAG Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2009
Oct 29, 2009 Conference Calls Today: 8:30-8:45 A.M. EDT
Oct 23, 2009 AMAG Pharmaceuticals Down 14.1% Since SmarTrend's Sell Recommendation
Oct 22, 2009 BiomedReports: News and FDA Updates for Curis (NASDAQ:CRIS), AMAG (NASDAQ:AMAG)
Oct 21, 2009 AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter Ended September 30, 2009
Oct 12, 2009 AMAG Pharmaceuticals Down 12.8% Since SmarTrend's Sell Recommendation
Oct 08, 2009 BiomedReports: News and FDA Updates for Unilife Medical Solutions (OTC:UNIFF), AMAG (NASDAQ:AMAG)
Oct 07, 2009 Associatesfortune.com: Stock Profiler.US Profiles Vivakor, Inc. & AMAG Pharmaceuticals, Inc.
Oct 07, 2009 AMAG Pharmaceuticals, Inc. Announces Data Presentations at the American Society of Nephrology (ASN) Renal Week Meeting
Oct 05, 2009 BUYINS.NET: AMAG Pharmaceuticals (AMAG) Daily Short Sale Trading Volume Through 10-2-09
Oct 05, 2009 AMAG Pharma (AMAG) Downgrade Alert, Watch for 0.9% Technical Downtrend Continuation
 
ZACKS COMMENTARY FOR AMAG
Nov 06, 2009 Zacks Equity Research: Report for AMAG
Jul 30, 2009 Zacks Blog: AMAG Pharma’s Feraheme Holds Promise
Jul 15, 2009 Zacks Blog: Zacks Analyst Blog Highlights: AMAG Pharmaceuticals Inc., Fresenius Medical Care AG & Co., Watson Pharmaceuticals, Inc., Sanofi-Aventis and ReneSola Ltd.
Jul 14, 2009 Zacks Blog: AMAG Kidney Drug Launched
Jul 02, 2009 Zacks Blog: Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and Montpelier
Jul 02, 2009 Bull of the Day: AMAG Pharmaceuticals (AMAG)
Jul 01, 2009 Zacks Blog: FDA Approves AMAG’s Feraheme
Jul 01, 2009 Zacks Blog: Company News for July 1, 2009
Jun 19, 2009 Zacks Blog: AMAG Awaits FDA Decision
Jun 01, 2009 Zacks Blog: Zacks Industry Outlook Highlights: Myriad Genetics, Onyx Pharmaceuticals Inc., AMAG Pharmaceuticals Inc., Dendreon and 3SBio Inc.
Jun 01, 2009 Zacks Analyst Interviews: Biotech Industry
May 29, 2009 Zacks Blog: Biotech Industry

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research